Currently the Director of Product Development Strategy with NAMSA, previously the Director of Global Regulatory at NAMSA, and a former member of the U.S. FDA. He holds a Ph.D. in Pharmacology from the University of Washington and a M.S. from the School of Biomedical Engineering at Drexel University. At NAMSA Dr. Goldenberg works with over 850 NAMSA associates to develop global strategies for success taking into account regulatory, clinical, testing and business considerations around the world. He has supported companies in direct interactions with the US FDA, several notified bodies, CFDA, ANVISA, MFDS, and many others global regulatory bodies. Prior to joining NAMSA Dr. Goldenberg founded a consulting company based in Shanghai supporting medical device market entry. Dr. Goldenberg understands not only what it takes to carry out scientific study, but also the importance of communicating it with the global scientific community to foster partnerships and collaboration, demonstrated by his strong publication record in such journals as Cell, Science, and Nature Cell Biology that have been cited over 900 times.